HHC
AMGN icon

Hutchin Hill Capital’s Amgen AMGN Stock Holding History

Hutchin Hill Capital’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-3,300
Closed -$568K – 725
2017
Q2 		$568K Sell
3,300
-6,500
-66% -$1.06M 0.02% 657
2017
Q1 		$1.61M Buy
+9,800
New +$1.63M 0.04% 375
2013
Q4 		– Sell
-26,500
Closed -$2.97M – 517
2013
Q3 		$2.97M Buy
+26,500
New +$2.87M 0.27% 76

Other funds holding AMGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Hutchin Hill Capital's AMGN Position: Q3 2017 in Review

Hutchin Hill Capital sold out of Amgen (AMGN) in Q3 2017, closing a stake of 3,300 shares — an estimated $568K sold.

Hutchin Hill Capital first reported a position in AMGN in Q3 2013 and held it in 3 quarters. The position peaked at $2.97M in Q3 2013. 1,606 funds tracked by Wall St. Rank hold AMGN as of Q3 2017.

  • Hutchin Hill Capital reported no remaining Amgen position as of Q3 2017 after selling out during the quarter.
  • Hutchin Hill Capital sold 3,300 Amgen shares in Q3 2017, an estimated $568K.
  • Hutchin Hill Capital first reported a position in Amgen in Q3 2013 and held it in 3 quarters.
  • Hutchin Hill Capital's Amgen position peaked at $2.97M in Q3 2013.
  • 1,606 funds tracked by Wall St. Rank held Amgen as of Q3 2017.

Based on Hutchin Hill Capital's 13F filing for Q3 2017, filed 14 Nov 2017.